Form D · Biotechnology
Avita Medical, Ltd.
Melbourne, C3 · CIK 0001762303
Offering snapshot reported Nov 27, 2019 · SEC filing
- Reported sold
- $15.4M Offering amount: $15.4M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 19, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 27, 2019 | Initial | $15,374,916 | No comparison | 9 | SEC filing |
| Feb 6, 2019 | Amendment | $14,370,886 | $5,440,253vs Dec 19, 2018 | 1 | SEC filing |
| Dec 19, 2018 | Initial | $8,930,633 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $461K
- Form D file number
- 021-354436
Source: Form D, filed Nov 27, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Rooney | Executive |
| Dale A Sander | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/ Level 330 Collins Street
Melbourne, C3, VIC 3000
Melbourne, C3, VIC 3000